Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors.

Estela García-Martín, R M Romero-Jiménez,Ofelia Baniandrés-Rodríguez,Vicente Escudero-Vilaplana,Juana Benedí-González,Paloma Morales de Los Ríos Luna,Ana Herranz-Alonso,María Sanjurjo-Sáez

European journal of hospital pharmacy : science and practice（2023）

引用 1|浏览3

暂无评分

摘要

Anti-IL-17 agents constitute an effective treatment for patients with moderate/severe plaque psoriasis and for longer. Dose reductions were associated with fewer lines of treatment, younger patients and absence of concomitant pathologies. ADR were minor and similar among the anti-IL-17.

查看译文

关键词

BIOTECHNOLOGY,DERMATOLOGY,PHARMACY ADMINISTRATION,PHARMACY SERVICE, HOSPITAL,Psoriasis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要